As Sussan Ley exits politics, her tenure as health minister is best remembered for driving some of the most structurally significant reforms to the Pharmaceutical Benefits Scheme in decades, reshaping pricing, governance, industry engagement, and patient access despite at times intense opposition. …
Sussan Ley's sometimes contentious but unquestionably consequential health legacy
February 15, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
Georgia Forrest
New Stories
-
A new prostate cancer technology moves closer to global trials after strong early results
March 12, 2026 - - Australian Biotech -
Cell therapy company Mesoblast names executive to guide clinical development and medical affairs
March 12, 2026 - - Australian Biotech -
Patrys moves toward first human trial for injectable delirium therapy
March 12, 2026 - - Australian Biotech -
Imugene launches $20 million capital raise to fund expansion of Azer Cel trials
March 12, 2026 - - Australian Biotech -
Australia at a crossroads as the nuclear medicine revolution gathers pace
March 12, 2026 - - Latest News -
New Zealand confirms earlier access to breakthrough cystic fibrosis medicines
March 12, 2026 - - Latest News -
Fundraising racing towards total target as teams and participants prepare to climb
March 11, 2026 - - Latest News